New product: Skyrizi (risankizumab) 150 mg solution for injection in pre-filled syringe

Risankizumab is a humanised indicated for the treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy.

Source:

electronic Medicines compendium